In glioblastoma patients, differences of quantitative T1 (qT1) maps acquired before and after contrast agent (CA) administration are visually compared to the respective differences of conventional T1-weighted (T1w) images. Quantitative T1-differences are determined in the following regions-of-interest (ROIs): (1) enhancing tumor, (2) edema, (3) 5mm-rim around (1)+(2), (4) control tissue contralateral to the tumor. T1w- and qT1-differences clearly show the enhancing tumor, but only the qT1-difference maps show signal enhancement in the edema, which is in line with elevated qT1-difference values in this ROI. This indicates most likely CA leakage due to tumor infiltration.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords